Lamprogen, Inc.
Bothell, WA Doing business as Lamprogen Inc.
- UEI
- K25TMBQBHAQ5
- CAGE
- 6R8V5
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3301 Monte Villa Pkwy #325, Bothell, WA 98021, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Deep immunophenotyping in tissue imaging - project summary there is a growing demand for deep phenotyping of single… | National Institute of General Medical Sciences | $1,701,480 | |
| An expanded 75-color panel of pdots for spectral multiplexing - project summary flow cytometry is widely used in basic… | National Institute of General Medical Sciences | $999,166 | |
| Significant expansion of spectral multiplexing in PCR - project summary there have been long-standing discussions… | National Institute of General Medical Sciences | $1,499,604 | |
| Pdot enabled cyclic imaging cytometry | National Institute of General Medical Sciences | $149,800 | |
| Ultra-bright fluorescent probes for flow cytometry | National Institute of General Medical Sciences | $1,400,082 |
About Lamprogen, Inc.
Lamprogen, Inc. is a corporate entity registered in SAM.gov since May 2, 2012, with its headquarters located in Bothell, Washington. The company appears to be a technology-focused research organization specializing in advanced fluorescent and spectroscopic technologies for biomedical applications. As a for-profit organization, Lamprogen, Inc. has been actively engaged in developing innovative nanotechnology solutions for scientific research, particularly in the domains of imaging, flow cytometry, and molecular diagnostics.
The company has been awarded multiple federal grants from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program, focusing on cutting-edge research in spectral multiplexing technologies. These grants, totaling approximately $850,740, support projects aimed at developing semiconducting polymer dots (PDots) with advanced fluorescence capabilities. Specifically, Lamprogen, Inc. has been working on expanding spectral multiplexing in various scientific domains, including tissue imaging (developing a 56-color panel for deep immunophenotyping), flow cytometry (creating a 75-color PDot panel), and PCR technologies (developing highly multiplexed PCR assays for clinical diagnostics). The research aims to improve resolution in cell subpopulation analysis, enhance diagnostic capabilities, and provide more efficient and cost-effective methods for molecular research and clinical screening. These innovative technologies have potential transformative applications in spatial biology, pathology workflows, and molecular diagnostics.
Quick answers
What is Lamprogen, Inc.'s UEI?
Lamprogen, Inc.'s Unique Entity ID (UEI) in SAM.gov is K25TMBQBHAQ5.
What is Lamprogen, Inc.'s CAGE code?
Lamprogen, Inc.'s CAGE code is 6R8V5.
Where is Lamprogen, Inc. located?
Lamprogen, Inc.'s physical address in SAM.gov is 3301 Monte Villa Pkwy #325, Bothell, WA 98021, USA.
Is Lamprogen, Inc. registered in SAM.gov?
Yes. Lamprogen, Inc.'s SAM.gov registration is active through January 28, 2027.
What is Lamprogen, Inc.'s most recent federal award?
Lamprogen, Inc.'s most recent federal grant award is Deep immunophenotyping in tissue imaging - project summary there is a growing demand for deep phenotyping of single… (R44GM161324), from National Institute of General Medical Sciences, on August 1, 2025.
On GovTribe
See Lamprogen, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors